ArticleBMC microbiology2026
Evaluation of MALDI-TOF MS for identification of clinical filamentous fungi in a routine mycology laboratory.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Validation of the Mycelium Transfer Method Coupled with MALDI-TOF MS for Rapid Identification of Filamentous Fungi.Pathogens (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMALDI-TOF MS (Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry) technology has become an effective tool in clinical mycology laboratories in recent years for the identification of pathogenic filamentous fungi.
methodsA total of 527 clinical specimens, comprising samples from both superficial and deep mycoses, were included in this study. Filamentous fungal samples isolated from various clinical specimens and identified using conventional methods between 2017 and 2018 at the Medical Microbiology Mycology Laboratory of Istanbul University-Cerrahpaşa Faculty of Medicine Hospital were analyzed using MALDI Biotyper Bruker Daltonik GmbH Revision 4 and the Filamentous Fungi database v3.0.
resultsIn the identification of mold samples, the highest scoring identification values were determined with the liquid cultivation and extraction method recommended by MALDI-TOF MS for filamentous fungi. A total of 46 different filament fungi species, including 6 dermatophytes and 40 non-dermatophyte filament fungi species, were identified from the clinical samples in the study. Of the total of 527 clinical samples, 27% (n = 142) were identified as having high reliability in the range of 1.8 to 3, and 20% (n = 103) as having low reliability in the range of 1.6 to 1.79. The total rate of identified filament fungi was successfully determined as 47% (n = 245).
conclusionsIn the practical experience of our medical mycology laboratory, we evaluated the current uses of MALDI-TOF MS and their practical application in daily routine. In the identification of mold species obtained from clinical samples by MALDI-TOF, it is important to meticulously prepare sample preparation protocols, use an identification strategy suitable for routine diagnosis, and continuously update libraries using advanced databases.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.